ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.00
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      62,873.07
      -1.36%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mesoblast Limited (MESO)

      7. Mesoblast Limited (MESO) News

      MESO Mesoblast Limited

      6.32
      0.17 (2.76%)
      Apr 26 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Mesoblast Limited MESO NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.17 2.76% 6.32 19:52:28
      Open Price Low Price High Price Close Price Prev Close
      6.04 6.04 6.36 6.24 6.15
      more quote information »

      Recent News

      Date Time Source Heading
      3/26/202409:25APSFDA Commentary Sends Biotech Soaring During Premarket Hours
      3/25/202422:34GLOBEUnited States Food & Drug Administration (FDA) Notifies..
      3/13/202419:30GLOBEMesoblast Successfully Completes Placement and Accelerated..
      3/10/202419:54GLOBEUnited States Food & Drug Administration (FDA) Supports..
      2/28/202417:57GLOBEMesoblast Reports Financial Results and Operational Update..
      2/26/202407:00GLOBEMesoblast Financial Results and Corporate Update Webcast
      2/14/202419:46GLOBEUnited States Food & Drug Administration (FDA) Grants..
      1/31/202421:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/30/202421:13GLOBEAppendix 4C Quarterly Activity Report for Quarter Ended..
      1/18/202419:28DJNMesoblast Gets FDA's Special Pediatric Designation for..
      1/18/202418:36GLOBEUnited States Food & Drug Administration (FDA) Grants..
      1/16/202406:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/04/202421:57EDGAR2Form F-6 POS - Post-effective amendments for immediately..
      12/22/202317:13EDGAR2Form F-6 POS - Post-effective amendments for immediately..
      11/26/202318:56GLOBEMesoblast Files for Orphan Drug and Pediatric Rare Disease..
      11/22/202313:35APSBiotech Shares Soar Following Major Announcement
      11/21/202318:32GLOBEMesoblast Partners With Blood and Marrow Transplant Clinical..
      10/30/202320:04GLOBEAppendix 4C Quarterly Activity Report for Quarter Ended..
      9/26/202306:18GLOBEJane Bell AM Appointed Chair of Mesoblast Audit and Risk..
      9/21/202303:30GLOBEKey Outcomes From FDA Type A Meeting and Mesoblast Next..
      9/06/202306:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      8/30/202319:07GLOBEMesoblast Reports Financial Results and Operational Update..
      8/29/202307:00GLOBEMesoblast Financial Results and Corporate Update Webcast
      8/04/202309:03DJNMesoblast ADSs Plunge Premarket on Latest FDA Rejection
      8/03/202320:10GLOBEMesoblast Receives Complete Response From U.S. Food and Drug..
      7/30/202320:31GLOBEAppendix 4C Quarterly Activity Report for Quarter Ended June..
      6/04/202320:21GLOBEMesoblast Director Philip R. Krause, M.D., Appointed to..
      5/25/202319:28GLOBEMesoblast Reports Operational and Financial Highlights for..
      5/24/202307:00GLOBEMesoblast Financial Results and Corporate Update Webcast
      4/27/202321:00GLOBEAppendix 4C Quarterly Activity Report

      Your Recent History

      NASDAQ
      MESO
      Mesoblast
      Delayed Upgrade Clock